Myriad Genetics Inc (MYGN)

MYGN (NASDAQ:Diversified Services) EQUITY
$34.07
pos +0.00
+0.00%
Today's Range: 33.66 - 35.26 | MYGN Avg Daily Volume: 929,200
Last Update: 02/27/15 - 3:59 PM EST
Volume: 0
YTD Performance: 0.03%
Open: $0.00
Previous Close: $34.96
52 Week Range: $31.56 - $42.50
Oustanding Shares: 71,118,496
Market Cap: 2,486,302,620
6-Month Chart
TheStreet Ratings Grade for MYGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 5 4 4
Moderate Buy 0 0 0 0
Hold 7 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 3 3 3 3
Mean Rec. 2.81 2.66 2.79 2.79
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 24.11
Price Earnings Comparisons:
MYGN Sector Avg. S&P 500
24.11 24.20 26.52
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
2.62% -6.99% 41.66%
GROWTH 12 Mo 3 Yr CAGR
Revenue 26.90 0.94 0.24
Net Income 19.80 0.75 0.20
EPS 27.60 1.08 0.27
Earnings for MYGN:
EBITDA 0.29B
Revenue 0.78B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (06/15) FY (06/16)
Average Estimate $0.39 $0.48 $1.53 $1.87
Number of Analysts 11 10 13 12
High Estimate $0.44 $0.51 $1.55 $2.29
Low Estimate $0.38 $0.45 $1.50 $1.60
Prior Year $0.60 $0.48 $2.43 $1.53
Growth Rate (Year over Year) -34.24% 0.83% -37.13% 22.13%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bearish
Feb 04, 2015 | 7:51 AM EST
MYGN was downgraded from Neutral to Underperform, Credit Suisse said. $30 price target. Estimates also cut, given the company's new gui...
Bullish
Feb 04, 2015 | 7:40 AM EST
MYGN was upgraded from Market Perform to Outperform, JMP Securities said. $50 price target. Stock is attractive, following a 15% declin...
Charting setups in Myriad Genetics, Clovis Oncology and Aegerion Pharma.
Bullish
Apr 02, 2014 | 8:16 AM EDT
MYGN raised its number, Jefferies said. Driven by unexpected boost to BRCA pricing. $33 price target. 
Bullish
Feb 07, 2014 | 8:25 AM EST
MYGN was upgraded from Underperform to Neutral, Credit Suisse said. $29 price target. Base business can hold up better than expected an...
Bullish
Feb 05, 2014 | 7:58 AM EST
MYGN was upgraded from Underperform to Market Perform, JMP Securities said. Company is executing well, despite increased competition.&n...
Bearish
Dec 30, 2013 | 7:41 AM EST
MYGN was downgraded from Market Perform to Underperform, JMP Securities said. $15 price target. BRCA pricing is lower than expected.&nb...
Bearish
Dec 03, 2013 | 8:16 AM EST
MYGN was downgraded from Outperform to Market Perform, JMP Securities said. Company could face lower reimbursement levels.
Bearish
Oct 21, 2013 | 8:02 AM EDT
MYGN was downgraded from Neutral to Underperform, Credit Suisse said. $20 price target. Company is facing increased competition.  ...
Bearish
Jun 14, 2013 | 8:40 AM EDT
MYGN was downgraded to Market Perform after a mixed ruling on gene patents, said Leerink Swann. With focus turning to cancer testing, s...

Columnist Conversations

Reports on Tuesday. I am getting a little concerned on how the 2015 guidance will come in.
JCP
Soz doing some more good stuff on retail today-- I loved the JCP piece.. Remember you can follow a writer now ...
Despite a big upgrade from Credit Suisse(from Neutral to Outperform)FDX is relatively flat today. The st...
The Market Vectors Gold Miners ETF (GDX) chart continues to exhibit characteristics of a classic cup-and-handl...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.